MedPath

se of technologies to monitor and guarantee the treatment of Tuberculosis among Migrants, Refugees and Stateless Persons in Brazil (MIRA-TB Project)

Phase 4
Conditions
Tuberculosis. Latent Tuberculosis. Tuberculosis, Pulmonary. Transients and Migrants. Refugees
L01.143.350
Registration Number
RBR-49dt8yj
Lead Sponsor
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals over 18 years old; both gender; international migrants, refugees, and stateless persons diagnosed through the verification of induration (greater than 5 mm) 72 hours after the application of the Tuberculin Test (TT), applied intradermally on the forearm and/or use of the Interferon-Gamma Release Assay (IGRA) in situations where the use of TT is not possible, and according to the protocols of the World Health Organization (WHO); migrants, refugees, and stateless persons with drug-resistant tuberculosis (DR-TB) identified through project screening and/or spontaneous demand at health services, diagnosed according to the protocols of the Ministry of Health (MoH), based on the Rapid Molecular Test (RMT), sputum smear microscopy, or sputum cultur

Exclusion Criteria

Lack of familiarity or difficulty using a smartphone; individuals under 18 years old; Brazilians; migrants, refugees, and stateless persons not residing

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath